Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
Resource Type
Article
Authors
Motzer, Robert J ; Russo, Paul ; Grünwald, Viktor ; Tomita, Yoshihiko ; Zurawski, Bogdan ; Parikh, Omi ; Buti, Sebastiano ; Barthélémy, Philippe ; Goh, Jeffrey C ; Ye, Dingwei ; Lingua, Alejo ; Lattouf, Jean-Baptiste ; Albigès, Laurence ; George, Saby ; Shuch, Brian ; Sosman, Jeffrey ; Staehler, Michael ; Vázquez Estévez, Sergio ; Simsek, Burcin ; Spiridigliozzi, Julia ; Chudnovsky, Aleksander ; Bex, Axel
Source
In The Lancet 11-17 March 2023 401(10379):821-832
Subject
Primary Research Articles
Language
ISSN
0140-6736